IMPACT REPORT: EXCITE International’s Risk-Reduction for Technology Adoption in the U.S.
March 19, 2024
Early technology review: towards an expedited pathway
CTA Technology Standards Forum - HealthFuture: The Shifting Paradigm of Health Technology Innovation and Evidence-Based Adoption
January 24, 2024
The white paper, available here, was composed based on a joint CTA/EXCITE International Technology Information Forum held in Chicago, May 2023.
Payers' Advisory Committee Guidance Document
April 14, 2023
A confidential Payers Advisory Committee Guidance document that lays out a comprehensive approach to U.S. payer perspectives is available to companies that engage with EXCITE for an Evidence & Technology Review. This provides insights into high level coverage determination considerations, ways to engage with Payers and an outline of the CPT codes.
Explore MedTech Webinar: U.S. Healthcare Payer Adoption – Key to coverage post FDA Approval
March 14, 2023
A virtual event, held on March 30th from 12pm - 1pm ET, the expert panel shared valuable and honest insights. Access the recording here.
EXCITE International Becomes a Member of the FDA's Early Payor Feedback Program
November 23, 2022It is a great pleasure to announce that EXCITE International has become a member of the FDA's Early Payor Feedback Program (EPFP) set up by the Center for Devices and Radiological Health (CDRH).
Learn More here
EXCITE International Evidence & Technology Review: Unprecedented Opportunity to Engage with the Largest U.S. Payers and Renowned Experts
October 7, 2022
Technologies that improve patient outcomes and deliver service efficiencies deserve to be well-integrated into healthcare systems. Unfortunately, the path to adoption is complex, and many companies get bogged down due to a poor understanding of what payers and health professionals require.
In response, the not-for-profit EXCITE International has developed a collaborative process for Evidence & Technology Review (ETR) that includes direct engagement with large payers and accomplished clinical experts.
Learn More here